Carisma Therapeutics Inc. (CARM)
0.44
-0.01 (-3.25%)
At close: Jan 15, 2025, 3:38 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -86.88M | -61.23M | -40.78M | -28.35M | -107.50M | -33.69M | -29.03M | 1.89M | -33.45M | -34.16M | -18.02M | -19.66M | -12.83M |
| Depreciation & Amortization | 2.84M | 6.09M | 682.00K | 448.00K | 219.00K | 208.00K | 285.00K | 178.00K | 366.00K | 410.00K | 438.00K | 448.00K | 364.00K |
| Stock-Based Compensation | 2.32M | 275.00K | 479.00K | 163.00K | n/a | n/a | 1.38M | 4.01M | 2.53M | 2.43M | 1.26M | 130.00K | 38.00K |
| Other Working Capital | -7.63M | 45.67M | 2.44M | -1.74M | -3.63M | 118.00K | 1.37M | -1.73M | 236.00K | 92.00K | 1.87M | -134.00K | 911.00K |
| Other Non-Cash Items | 5.99M | -19.65M | 834.00K | 1.18M | 72.76M | 10.03M | 11.70M | 4.12M | 1.48M | 894.00K | 1.18M | 71.00K | 12.00K |
| Deferred Income Tax | n/a | 21.75M | n/a | n/a | -1.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -5.44M | 45.20M | 1.46M | -453.00K | -3.10M | 578.00K | 611.00K | -2.47M | -976.00K | 1.11M | 1.66M | -84.00K | 1.54M |
| Operating Cash Flow | -81.18M | -7.57M | -37.33M | -27.01M | -37.52M | -22.83M | -17.77M | 2.62M | -34.53M | -29.31M | -13.49M | -19.09M | -10.87M |
| Capital Expenditures | -1.13M | -4.66M | -1.87M | -440.00K | -136.00K | -2.00K | n/a | n/a | -287.00K | -137.00K | n/a | -110.00K | -805.00K |
| Acquisitions | n/a | 30.00K | n/a | n/a | n/a | n/a | 98.00K | 461.00K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -34.46M | -90.90M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 108.00M | 63.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -30.00K | n/a | n/a | n/a | n/a | 98.00K | 461.00K | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 72.41M | -32.56M | -1.87M | -440.00K | -136.00K | -2.00K | 98.00K | 461.00K | -287.00K | -137.00K | n/a | -110.00K | -805.00K |
| Debt Repayment | -1.30M | 34.13M | n/a | n/a | n/a | n/a | n/a | -14.12M | 4.12M | 5.25M | 4.69M | 992.00K | -583.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.00K | -2.00K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 32.24M | -35.92M | 15.96M | 72.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 62.18M | 35.77M | 15.96M | 72.26M | 35.36M | 58.58M | 7.00M | -13.82M | 16.84M | 75.56M | 13.55M | 26.38M | 10.45M |
| Net Cash Flow | 53.41M | -138.44M | -23.24M | 44.81M | -2.30M | 35.74M | -10.66M | -10.74M | -17.98M | 46.12M | 60.00K | 7.18M | -1.23M |
| Free Cash Flow | -82.31M | -12.23M | -39.20M | -27.45M | -37.66M | -22.83M | -17.77M | 2.62M | -34.82M | -29.44M | -13.49M | -19.20M | -11.67M |